C Factory |China C Vagadziri, Vatengesi

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Crisaborole

Zita reAPI Indication Innovator Patent Expiry Date (The US)

Crisaborole Atopic Dermatitis uye Eczema Pfizer Jun. 11, 2026

kubvunza tsanangudzo
Kanagliflozin

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Kanagliflozin Type 2 chirwere cheshuga Mumba √

kubvunza tsanangudzo
Chlorothiazide

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Chlorothiazide Diuretics USP/EP

kubvunza tsanangudzo
Captopril

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Captopril Hypertension USP/EP √ √

kubvunza tsanangudzo